Abdominal Aortic Aneurysm Clinical Trial
— RESPONSEOfficial title:
Relation betwEen Abdominal Aorta and Carotid Artery Responses to SymPathetic stimulatiON uSing duplEx Ultrasound
Verified date | October 2020 |
Source | Rijnstate Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Abdominal aortic aneurysm (AAA) is a common vascular disease and associated with risk of
rupture, but also with a high cardiovascular (CV) event rate. A key difficulty in AAA is
predicting these life-threatening complications. Recent studies suggest that the endothelial
function of the abdominal aorta might have a correlation with the disease development. A
novel, easy to perform, non-invasive test can assess central artery endothelial function
(i.e. the carotid artery reactivity (CAR)). The CAR test is based on the cold pressure test
(CPT), which induces sympathetic stimulation by placing one hand in cold water. Using duplex
ultrasound, central artery blood flow and diameter responses can be examined.
Previous work has demonstrated that the CPT is associated with an increase in abdominal
aortic diameter, whilst others found that the carotid and coronary artery diameter also shows
dilation. Interestingly, a previous study found a strong correlation between carotid and
coronary artery diameter responses to the CPT, whilst these artery responses show independent
prognostic value for future cardiovascular events in patients with peripheral arterial
disease. Possibly, similarity may be present in central artery reactivity to the CPT. To
date, no study examined whether carotid and aorta responses are in agreement during the CPT.
Given the potential importance of central artery vasoreactivity for AAA, the CAR-test may
have potential in this group, especially given the relative simplicity of measuring the
carotid artery.
The aim of this explorative study is to investigate the correlation between the magnitude of
the abdominal aorta and the carotid artery diameter and blood flow responses during the
sympathetic stimulation (using the cold pressor test) between healthy young, healthy older
and individuals with AAA.
Status | Completed |
Enrollment | 60 |
Est. completion date | October 5, 2020 |
Est. primary completion date | August 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Young healthy group: Male or female between the age of 18 and 40 years old; - Older healthy group: Male or female, which are age-/sex-matched with the AAA patients group; - AAA patients group: Male or female with an abdominal aortic aneurysm who is still under surveillance, with a diameter between 3.0 and 5.0 cm and at least 18 years old. These patients may participate in the 1-2-3 Trial, which is a similar approved investigation by CMO region Arnhem-Nijmegen with registration number 2019-5216. - Informed consent form understood and signed; Exclusion Criteria: - Psychiatric or other conditions that may interfere with the study; - Participating in another clinical study, interfering on outcomes; - With regard to the necessary quality of the ultrasound images, BMI = 30 kg/m2; - Increased risk for coronary spasms (score Rose-questionnaire =2; this questionnaire can be found in the Appendix); - Known carotid artery disease - Presence of Raynaud's phenomenon, Marfan syndrome, chronic pain syndrome at upper extremity(s), presence of an AV fistula or shunt, open wounds to the upper extremity(s), and/or scleroderma associated with placing the hand in ice water; - Recent (<3 months) presence of angina pectoris, myocardial infarction, cerebral infarction, and/or heart failure, or PAD treatment. - Healthy groups: - Systolic blood pressure >140 and/or diastolic blood pressure >90 - Cardiovascular history - Antihypertensive medication |
Country | Name | City | State |
---|---|---|---|
Netherlands | Rijnstate Hospital | Arnhem | Gelderland |
Netherlands | Radboudumc | Nijmegen | Gelderland |
Lead Sponsor | Collaborator |
---|---|
Rijnstate Hospital | Radboud University |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Demographic characteristics | Gender | Baseline | |
Other | Demographic characteristics | If current smoker | Baseline | |
Other | Demographic characteristics | Height | Baseline | |
Other | Demographic characteristics | Weight | Baseline | |
Other | Demographic characteristics | Medical history | Baseline | |
Other | Demographic characteristics | Blood pressure | Baseline | |
Other | Demographic characteristics | Heart rate | Baseline | |
Other | Medication use | Ask about: Statins | Baseline | |
Other | Medication use | Ask about: Beta-blockers | Baseline | |
Other | Medication use | Ask about: Sympathicomimetica | Baseline | |
Other | Medication use | Ask about: Anti-platelets | Baseline | |
Other | Medication use | Ask about: Anti-coagulants | Baseline | |
Other | Medication use | Ask about: Anti-hypertensives (questioned) | Baseline | |
Primary | CAR-test | Percentage of vasodilation/vasoconstriction to the CAR test at the common carotid artery | Baseline | |
Primary | CAR-test | Percentage of vasodilation/vasoconstriction to the CAR test at the abdominal aorta | Baseline | |
Secondary | CAR-test | Magnitude of the blood flow and perfusion response of the carotid artery | Baseline | |
Secondary | CAR-test | Timing of the blood flow and perfusion response of the carotid artery | Baseline | |
Secondary | CAR-test | Magnitude of the blood flow and perfusion response of the abdominal aorta | Baseline | |
Secondary | CAR-test | Timing of the blood flow and perfusion response of the abdominal aorta | Baseline | |
Secondary | CAR-test | Blood pressure response | Baseline | |
Secondary | CAR-test | Heart rate response | Baseline | |
Secondary | Age | Age | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04227054 -
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks
|
N/A | |
Active, not recruiting |
NCT03687489 -
Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System
|
N/A | |
Active, not recruiting |
NCT03507413 -
Metformin Therapy in Non-diabetic AAA Patients
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05756283 -
The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair
|
N/A | |
Not yet recruiting |
NCT04089241 -
Fusion of CT Angiography With 3D Contrast Ultrasound as a Method for Follow up for Endovascular Aneurysm Repair
|
N/A | |
Active, not recruiting |
NCT02604303 -
A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms
|
||
Terminated |
NCT01843335 -
Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair
|
N/A | |
Terminated |
NCT02469376 -
Evaluation of a New Imagingtechnologie for Thrombosis
|
Phase 1 | |
Completed |
NCT02229006 -
Sodium Fluoride Imaging of Abdominal Aortic Aneurysms
|
N/A | |
Completed |
NCT02224794 -
LIFE Study: Least Invasive Fast-Track EVAR
|
||
Terminated |
NCT01425242 -
Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension
|
N/A | |
Completed |
NCT01118520 -
AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)
|
Phase 2 | |
Completed |
NCT00746122 -
Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair
|
N/A | |
Completed |
NCT03952780 -
Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
|
||
Completed |
NCT00583414 -
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
|
N/A | |
Recruiting |
NCT05864560 -
Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
|
||
Completed |
NCT01683084 -
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
|
Phase 4 | |
Active, not recruiting |
NCT03180996 -
Global Fenestrated Anaconda Clinical sTudy
|
||
Completed |
NCT02493296 -
The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
|
||
Completed |
NCT03320408 -
Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers
|